Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Changes in Beneficial Ownership · 4

Quest Diagnostics Inc.

DGXNYSEEQUITYCurrent

Changes in Beneficial Ownership

Filed Jul 27, 2026Accepted Jul 27, 2026, 4:35 PM EDTFiling CIK 1022079Accession 0001022079-26-000086
Share

Structured filing — 4

wk-form4_1785184536.xml

Open full document ↗

Filing details

Report period
2026-07-22
Issuer
QUEST DIAGNOSTICS INC
Issuer CIK
0001022079
Trading symbol
DGX

Reporting owner 1

Name
KUPPUSAMY KARTHIK
Reporting owner CIK
0001955217
Relationship
Officer
Officer title
SVP, Clinical Solutions
Address
500 PLAZA DRIVE, C/O QUEST DIAGNOSTICS INC, SECAUCUS, NJ, 07094

Non-derivative transactions

Non-derivative transactions · 1 reported row
SecurityTransaction dateCodeAmountA / DPrice (USD)Owned afterOwnershipTimeliness
Common Stock2026-07-22L · Form 537[F1]A206.80713,557[F2]DE
Table key
L · Form 5
Small acquisition under Rule 16a-6
A
Acquired
D
Direct

Non-derivative holdings

Non-derivative holdings · 2 reported rows
SecurityAmount ownedOwnershipNature of ownership
Common Stock358IBy Trust
Common Stock1,691[F3]I401(k)
Table key
I
Indirect

Footnotes

F1
Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.↩ 1
F2
The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4.↩ 1
F3
These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under the Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.↩ 1

Signature 1

Signed
Sean D. Mersten, Attorney in Fact for Karthik Kuppusamy
Date
2026-07-27

Company context

Quest Diagnostics works across healthcare to create a healthier world, one life at a time. We help connect people, from clinicians to consumers, with laboratory insights that illuminate a path to better health. With a focus on delivering smarter, simpler testing, our insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management. Quest Diagnostics serves half the physicians and hospitals in the United States and one in three adult Americans each year, and our nearly 60,000 employees work together to deliver diagnostic insights that inspire actions to transform lives. www. QuestDiagnostics.com.

Current securities

Recent company filings

  1. SCHEDULE 13G - filed by STATE STREET CORP regarding QUEST DIAGNOSTICS INCNov 10, 2026
  2. 10-Q filingOct 23, 2026
  3. Other EventsOct 22, 2026
  4. Results of Operations and Financial ConditionOct 22, 2026
  5. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory ArrangementsOct 6, 2026

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.